Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
Return to: PBR Home | Automation
Today in Automation

Automation

Novartis to use CRISPR technology platforms for new medicines Swiss pharmaceutical firm Novartis has signed collaboration and licensing agreements with Intellia Therapeutics and Caribou Biosciences to develop new medicines and drug discovery tools with CRISPR genome editing technology. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

Enlivex secures EU orphan drug status for ApoCell to treat GvHD
By PBR Staff Writer
Israel-based Enlivex Therapeutics has received orphan drug status from the European Medicines Agency (EMA) for its lead product candidate, ApoCell, to prevent graft-versus-host disease (GvHD).
News
Syncona, UCLB form cancer immunotherapy firm Autolus
Syncona and UCL Business, the wholly-owned technology transfer company of University College London, announce the creation of Autolus Limited, a biopharmaceutical company focused on the development and commercialisation of next-generation engineered T-cell therapies for haematological and solid tumours.
News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
News